Aarti Pharmalabs Limited has informed the Exchange regarding 'Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015'.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 1.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On 22nd March 2026, a minor chemical leak occurred at Aarti Pharmalabs' Unit-VI in MIDC Tarapur (Palghar) while loading dimethyl sulphate into a tanker. The leak was cleared immediately, but 22 workers were taken to a local hospital as a precaution, with more than half already discharged. An FIR has been registered and an investigation is underway. The company confirmed there was no loss of life or property damage, and normal plant operations were safely restored within 24 hours. The incident is covered by insurance, and the company has stated no financial loss has occurred.
Short-term impact is limited as operations resumed within 24 hours with no loss of life, property damage, or financial loss. However, the FIR registration and investigation could draw regulatory and ESG scrutiny, potentially affecting sentiment in the near term.